A new electrical stimulation therapy for spinal muscle atrophy (SMA) has shown promise in reactivating motor neurons and ...

A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...

Paradromics, Inc., a global leader in high-data rate brain-computer interface (BCI) technology, announced a strategic ...

Over the past nine years, patients with spinal muscular atrophy have seen the number of FDA-approved treatment options for ...

Paradromics announced today that it received a strategic investment from NEOM, a region taking shape in Saudi Arabia.

AUSTIN, Texas- Paradromics, Inc., a global leader in high-data rate brain-computer interface (BCI) technology, announced a ...

Motor neuron disease (MND), often referred to by the name of one of its varieties, ALS, is a degenerative condition that ...

More than 15 million people worldwide are living with spinal cord injury (SCI), which can affect their sensory and motor ...

The human sense of touch is a complex system that integrates diverse sensations such as pain, temperature, and pleasant ...

A neurosurgeon and a neuroscientist discover promising new ways to help people with spinal cord injuries walk again ...

Spinal cord compression (SCC) occurs in 5% to 30% of the oncology population and affects patient function, comfort, and general quality of life. Patients with lung cancer, breast cancer ...

Jan. 22, 2025 — Following the lead of previous work on mRNA-based vaccines, therapies for spinal cord injuries and more, the method relies upon mineral-coated microparticles to deliver mRNA that ...